Cuban COVID vaccine Abdala 92 percent ‘effective’, maker says

Share on facebook
Facebook
Share on twitter
Twitter

According to the Cuban government, its Abdala coronavirus vaccine has shown 92.28 per cent efficacy in the last stage of clinical trials.

“It has great scientific relevance and a potential medical impact. Just ten months after initiating the projects in the laboratories of the CIGB (Genetic Engineering and Biotechnology Centre) and the Finlay vaccine institute,” Rolando Perez, Cuba’s director of science and innovation of Biocubafarma, said.

Several countries including Venezuela, Vietnam, Argentina and Mexico have reportedly expressed an interest in buying the vaccines produced by Cuba.

Under American sanctions, Cuba has a long tradition of making its own vaccines, dating back to the 1980s. 

Nearly 80 per cent of its vaccines are produced locally and it hopes to come up with the first locally-produced coronavirus shot in Latin America. 

Scroll to Top